ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol.51, no.8, pp.3020-3022, 2007 (SCI-Expanded)
Article / Article
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Bursa Uludag University Affiliated:
Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of < 400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.